![DECT in diagnosing and monitoring crystal deposition arthritis](https://www.essr.org/content-essr/uploads/2023/09/Grun-beige-einfache-Prasentation-2023-09-15T111601.605-1080x675.png)
![DECT in diagnosing and monitoring crystal deposition arthritis](https://www.essr.org/content-essr/uploads/2023/09/Grun-beige-einfache-Prasentation-2023-09-15T111601.605-1080x675.png)
![DECT in diagnosing and monitoring crystal deposition arthritis](https://www.essr.org/content-essr/uploads/2023/09/Grun-beige-einfache-Prasentation-2023-09-15T111601.605-1080x675.png)
How to monitor musculoskeletal manifestations of neurofibromatosis type-1 and tuberous sclerosis
![DECT in diagnosing and monitoring crystal deposition arthritis](https://www.essr.org/content-essr/uploads/2023/09/Grun-beige-einfache-Prasentation-2023-09-15T111601.605-1080x675.png)
Seronegative SpA and its treatment monitoring
![DECT in diagnosing and monitoring crystal deposition arthritis](https://www.essr.org/content-essr/uploads/2023/09/Grun-beige-einfache-Prasentation-2023-09-15T111601.605-1080x675.png)
Monitoring modern treatment response in arthritis – findings in MRI and ultrasound
![DECT in diagnosing and monitoring crystal deposition arthritis](https://www.essr.org/content-essr/uploads/2023/09/Grun-beige-einfache-Prasentation-2023-09-15T111601.605-1080x675.png)
EUROPEAN FORUM FOR EDUCATION AND RESEARCH OF MUSCULOSKELETAL RADIOLOGY